Controlled trial of enviroxime against natural rhinovirus infections in a community - PubMed (original) (raw)
Clinical Trial
Controlled trial of enviroxime against natural rhinovirus infections in a community
F D Miller et al. Antimicrob Agents Chemother. 1985 Jan.
Abstract
The therapeutic effect of intranasally administered enviroxime was tested against naturally occurring common colds. The double-blind evaluation was carried out in Tecumseh, Mich., during a period when rhinoviruses are usually the principal pathogen. Rhinovirus transmission followed the typical pattern during this period of study. Although there were trends indicating greater therapeutic effectiveness for enviroxime when certain nasal symptoms were considered, there were no consistent statistically significant differences between treated and untreated groups. Results were unchanged when illnesses in different periods or associated with rhinovirus isolation were examined. It was concluded that no therapeutic effect of enviroxime was demonstrated.
Similar articles
- Topical enviroxime against rhinovirus infection.
Levandowski RA, Pachucki CT, Rubenis M, Jackson GG. Levandowski RA, et al. Antimicrob Agents Chemother. 1982 Dec;22(6):1004-7. doi: 10.1128/AAC.22.6.1004. Antimicrob Agents Chemother. 1982. PMID: 6297380 Free PMC article. Clinical Trial. - Therapeutic activity of enviroxime against rhinovirus infection in volunteers.
Phillpotts RJ, Wallace J, Tyrrell DA, Tagart VB. Phillpotts RJ, et al. Antimicrob Agents Chemother. 1983 May;23(5):671-5. doi: 10.1128/AAC.23.5.671. Antimicrob Agents Chemother. 1983. PMID: 6870216 Free PMC article. Clinical Trial. - Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection.
Hayden FG, Gwaltney JM Jr. Hayden FG, et al. Antimicrob Agents Chemother. 1982 Jun;21(6):892-7. doi: 10.1128/AAC.21.6.892. Antimicrob Agents Chemother. 1982. PMID: 6287928 Free PMC article. Clinical Trial. - [Chemoprophylaxis and chemotherapy of common colds caused by rhinoviruses: overview and outlook].
Werner GH. Werner GH. Bull Acad Natl Med. 1992 May;176(5):669-81. Bull Acad Natl Med. 1992. PMID: 1330221 Review. French. - Effects on the nasal mucosa of upper respiratory viruses (common cold).
Winther B. Winther B. Dan Med Bull. 1994 Apr;41(2):193-204. Dan Med Bull. 1994. PMID: 8039434 Review.
Cited by
- From the "One-Molecule, One-Target, One-Disease" Concept towards Looking for Multi-Target Therapeutics for Treating Non-Polio Enterovirus (NPEV) Infections.
Roux H, Touret F, Rathelot P, Vanelle P, Roche M. Roux H, et al. Pharmaceuticals (Basel). 2024 Sep 16;17(9):1218. doi: 10.3390/ph17091218. Pharmaceuticals (Basel). 2024. PMID: 39338380 Free PMC article. Review. - Evaluation of 3D Human Intestinal Organoids as a Platform for EV-A71 Antiviral Drug Discovery.
Masmoudi F, Santos-Ferreira N, Pajkrt D, Wolthers KC, DeGroot J, Vlaming MLH, Rocha-Pereira J, Buti L. Masmoudi F, et al. Cells. 2023 Apr 12;12(8):1138. doi: 10.3390/cells12081138. Cells. 2023. PMID: 37190047 Free PMC article. - Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics.
Li Z, Ji W, Chen S, Duan G, Jin Y. Li Z, et al. Vaccines (Basel). 2023 Mar 1;11(3):571. doi: 10.3390/vaccines11030571. Vaccines (Basel). 2023. PMID: 36992155 Free PMC article. - Therapeutics for fulminant hepatitis caused by enteroviruses in neonates.
Wang LC, Tsai HP, Chen SH, Wang SM. Wang LC, et al. Front Pharmacol. 2022 Oct 20;13:1014823. doi: 10.3389/fphar.2022.1014823. eCollection 2022. Front Pharmacol. 2022. PMID: 36339581 Free PMC article. Review. - Enterovirus A71 antivirals: Past, present, and future.
Wang J, Hu Y, Zheng M. Wang J, et al. Acta Pharm Sin B. 2022 Apr;12(4):1542-1566. doi: 10.1016/j.apsb.2021.08.017. Epub 2021 Aug 20. Acta Pharm Sin B. 2022. PMID: 35847514 Free PMC article.
References
- J Infect Dis. 1980 Jan;141(1):87-91 - PubMed
- Lancet. 1981 Jun 20;1(8234):1342-4 - PubMed
- Antimicrob Agents Chemother. 1982 Jun;21(6):892-7 - PubMed
- Antimicrob Agents Chemother. 1983 May;23(5):671-5 - PubMed
- Am J Epidemiol. 1972 Nov;96(5):352-60 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical